Australia's Genetic Technologies jumps on new risk assessment test

Genetic Technologies

22/03/2024 01:24

** Shares of Genetic Technologies  GTG.AX  rise as much as
32.1% to $0.185, posting their biggest intraday percentage gain
since Nov 24, 2023
    ** Stock hits its highest level since Dec 18, 2023
    ** The molecular diagnostics co announces a risk assessment
test for serious diseases
    ** Says test includes over 200 genes to identify hereditary
disease risk associated with most common cancers, cardiovascular
disease, and type 2 diabetes
    ** Adds test enables doctors to identify nearly 100% of
people at risk of disease going beyond family history
    ** Over 280,000 shares change hands, compared with the
30-day average volume of 56,430 
    ** Stock up 3.7% YTD, based on last close



 (Reporting by Aaditya Govind Rao in Bengaluru)
 ((Aaditya.govindrao@thomsonreuters.com;))